Skip to content
value.today

Catalyst Biosciences Inc.

Total raised
$64 M
5 rounds on record
Latest round
$2 M
May 2015
First round on record
Dec 2008
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Catalyst Biosciences Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2015$2 MNo. 5Under $2 million

Catalyst Biosciences Inc.: Raise no. 5, May 2015

Investors in this round

10 investors had bought by the notice of Jul 13, 2015: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Fletcher Payne · Executive Officer
  • Nassim Usman · Executive Officer, Director
  • Asish Xavier · Director
  • Augustine Lawlor · Director
  • Harold Selick · Director
  • Jeff Himawan · Director
  • Michael Powell · Director
  • Ralph Christoffersen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen Thau, Secretary. Source: SEC Form D and 1 amendment, newest notice filed Jul 13, 2015. Read the notice at the SEC.

debt, optionsSEC
Jan 2015$3 MNo. 4$2 to $10 million

Catalyst Biosciences Inc.: Raise no. 4, Jan 2015

Investors in this round

11 investors had bought by the notice of Feb 3, 2015: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $5 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Nassim Usman · Executive Officer, Director
  • Asish Xavier · Director
  • Augustine Lawlor · Director
  • Harold Selick · Director
  • Jeff Himawan · Director
  • Michael Powell · Director
  • Ralph Christoffersen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen B. Thau, Secretary. Source: SEC Form D, newest notice filed Feb 3, 2015. Read the notice at the SEC.

equitySEC
Apr 2014$5 MNo. 3$2 to $10 million

Catalyst Biosciences Inc.: Raise no. 3, Apr 2014

Investors in this round

18 investors had bought by the notice of Apr 23, 2014: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
$3,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Nassim Usman · Executive Officer, Director
  • Asish Xavier · Director
  • Augustine Lawlor · Director
  • Harold Selick · Director
  • Jeff Himawan · Director
  • Michael Powell · Director
  • Ralph Christoffersen · Director
  • Steven Burrill · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen B. Thau, Secretary. Source: SEC Form D, newest notice filed Apr 23, 2014. Read the notice at the SEC.

equity, optionsSEC
Sep 2012$13 MNo. 2$10 to $50 million

Catalyst Biosciences Inc.: Raise no. 2, Sep 2012

Investors in this round

21 investors had bought by the notice of Sep 25, 2012: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $19 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Edwin Madison · Executive Officer
  • Nassim Usman · Executive Officer, Director
  • Asish Xavier · Director
  • Augustine Lawlor · Director
  • Barry Selick · Director
  • Jeff Himawan · Director
  • Ralph Christoffersen · Director
  • Steve Burrill · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen B. Thau, Secretary. Source: SEC Form D, newest notice filed Sep 25, 2012. Read the notice at the SEC.

equitySEC
Dec 2008$40 MNo. 1$10 to $50 million

Catalyst Biosciences Inc.: Raise no. 1, Dec 2008

Investors in this round

10 investors had bought by the notice of Dec 8, 2008: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$40 M of $40 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$408,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in De

People named in the notice

  • Edwin Madison · Executive Officer
  • Erik Wiberg · Executive Officer
  • Nassim Usman · Executive Officer, Director
  • Todd Lorenz · Executive Officer
  • Asish Xavier · Director
  • Augustine Lawlor · Director
  • Barry Selick · Director
  • Jeff Himawan · Director
  • Ralph Christoffersen · Director
  • Steve Burrill · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Seaview Securities LLC (CRD 126180) · New York, NySold in no state named

Signed by Stephen Thau, Secretary. Source: SEC Form D, newest notice filed Dec 8, 2008. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Catalyst Biosciences Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2015).

    SEC Form D · Jul 2015

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jul 2015

That is all the official record says: Catalyst Biosciences Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Catalyst Biosciences Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 21 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Catalyst Biosciences Inc.
NameRoleNamed in
Fletcher PayneExecutive officerJul 2015
Nassim UsmanExecutive officerJul 2015
Edwin MadisonExecutive officerSep 2012
Erik WibergExecutive officerDec 2008
Todd LorenzExecutive officerDec 2008
Asish XavierDirectorJul 2015
Augustine LawlorDirectorJul 2015
Harold SelickDirectorJul 2015
Jeff HimawanDirectorJul 2015
Michael PowellDirectorJul 2015
Nassim UsmanDirectorJul 2015
Ralph ChristoffersenDirectorJul 2015
Steven BurrillDirectorApr 2014
Barry SelickDirectorSep 2012
Steve BurrillDirectorSep 2012